Transcription
This stock was trading above $50. Today, it's below one. And yet, this morning traders started piling back in. That's the penny stock world for you. No institutional analysts, no Bloomberg terminals, just traders who've spotted something the crowd hasn't, placing their bets early. Today, we're looking at three of those bets: A biotech making a violent move, a thermal tech company sitting right inside the AI boom, and a cannabis name that's been beaten so badly its chart is starting to look like a loaded spring. These are our three penny stock picks for June 21st, and by the end of this video, you'll know exactly why each one is moving and whether any of them deserve a spot on your watchlist. Let's get into it.
First up, GNPX. The company behind this ticker is a clinical stage biopharmaceutical firm operating in healthcare. And biotech penny stocks, as anyone who's played in this space knows, are a completely different animal from everything else in the market.
They don't move on earnings beats or revenue guidance. They move on science, on trial results, on pipeline updates. One good data readout and the stock can triple before you've had your morning coffee. One failed study and it's gone before lunch. That's the game. And right now, GNPX is making exactly the kind of move that gets traders' attention. Up 22 and 1/2% today, sitting at 59 cents after opening near 48. But here's what makes this more than just a random penny spike. Volume today is running at more than double its normal daily average, more than double. In a stock with a float of only 10.6 million shares, one of the tightest floats you'll find anywhere in the market, that kind of volume surge is significant. A tight float means there simply aren't many shares available to trade. So, when buyers show up in force, the price moves fast, and it moves hard. That's the mechanic behind today's move. The stock hit a high of 63 cents intraday, and where it holds from here will tell us a lot about whether this is genuine accumulation or just a one-day spike with no follow-through.
The bull case is the float and the history. This stock traded at $55 within the last 52 weeks. It's now at 59 cents. If anything changes fundamentally – a trial update, a partnership, any positive news out of the pipeline – the re-rating potential in a stock with this kind of tight float is enormous. The bear case is the same history in reverse. A stock doesn't fall from $55 to 59 cents by accident. Something went wrong, and until you understand what that was and what's changed, buying this is pure speculation. For traders comfortable with that risk, GPNX is worth watching. For everyone else, do your homework first.
Now, let's talk about KULR technology, and this one has a genuinely compelling story behind it. KULR makes thermal energy management systems, technology that controls and dissipates heat inside batteries, electronics, and high-performance computing systems. That might sound like a niche industrial product, but think about what the world actually needs right now: Data centers running AI workloads around the clock, generating enormous amounts of heat. Electric vehicle batteries that degrade and fail when they overheat. Satellites and defense systems that cannot afford thermal failure in the field. KULR is building solutions for all of it. And in a market obsessed with AI infrastructure, a company that solves one of AI's most fundamental physical problems – heat – is exactly the kind of under-the-radar name that starts attracting serious attention.
The stock is up 11 and a half percent today, sitting near $4. And what's interesting here is that this isn't a volume-driven spike. Volume is actually slightly below average today, which means this move is price-led. Buyers are simply willing to pay more. That tends to be a healthier, more sustainable kind of momentum than a pure volume surge. The RSI is sitting right at 50, perfectly neutral, meaning the stock hasn't gotten overheated or overextended. There's room to move. The key level to watch is $4, a clean psychological round number that the stock has been flirting with all session. If KULR can close above four with conviction, the next target becomes the 20-day moving average just above 420. Get through that, and traders will start eyeing the upper end of the 52-week range near $8.
The bull case is the AI infrastructure narrative, and it's a strong one. Every dollar spent building AI data centers is indirectly a dollar that needs thermal management. KULR already has real contracts in aerospace and defense, which gives it credibility that most penny stock tech companies simply don't have. If revenue starts growing alongside the AI spending wave, this stock could look very cheap at current prices in 12 months. The bear case is execution risk. KULR is a small company in a competitive space, still trading below its medium-term moving averages, and the broader trend has been downward. Until the stock reclaims those levels, bulls need to be patient. This isn't a lottery ticket; it's a thesis play, and thesis plays require time.
Finally, let's talk about ACB, Aurora Cannabis. And yes, cannabis. Look, the sector has had one of the most brutal multi-year collapses in recent market history. The bubble burst, the promises weren't kept, and investors paid a brutal price. Aurora is one of the survivors, one of the largest cannabis producers in the world, still operating, still in business.
After years of restructuring, cost-cutting, and painful dilution, the stock today is barely moving, up just a third of a percent at 293. So, why are we talking about it? Because of one number: the RSI. It's sitting at exactly 30. That's the technical threshold that defines oversold territory. It means this stock has been sold so hard and so consistently that the selling pressure may finally be reaching exhaustion. And here's the thing that makes it more interesting: Volume today is running above average, even though the price has barely budged. More buyers showing up on a flat price day is sometimes the earliest sign of quiet accumulation before a move begins. The stock is sitting just 20 cents above its 52-week low. The downside from here is limited in absolute terms. The upside, if any catalyst materializes, could be significant.
The bull case is straightforward. If federal cannabis reform in the United States ever gets real traction, Aurora, as one of the biggest names in the space, gets re-rated immediately. Full stop. The bear case is that this same catalyst has been coming soon for years, and the stock has done nothing but fall while people waited. Aurora has disappointed its investors repeatedly, and at under $3, it's a stock that demands patience and a high tolerance for uncertainty. This is not a stock for someone who needs the market to reward them quickly.
So, here's where we land. GNPX is a high-volatility biotech speculation, the kind of play that can work beautifully if you've done your research on the pipeline, and burn you badly if you haven't. KULR is the most compelling story of the three: a real technology, a real market need, and a narrative that is only growing stronger as AI infrastructure spending accelerates. And ACB is the contrarian recovery watch, beaten down, oversold, and waiting for a catalyst that may or may not ever come. None of these are guaranteed wins. None of them ever are in this space, but all three are worth understanding because the traders who make money in penny stocks aren't the ones chasing moves blindly. They're the ones who understood the story before everyone else did.
What do you think? Is one of these stocks a hidden opportunity or just another wave of market hype? Drop your take in the comments. I read every single one. And if this kind of breakdown is useful to you, hit the like button and subscribe because we do this every single day on Financial Codes. See you in the next one.